Search Results for 'R'
Contract Service Directory Companies
Microsite Companies
Featured Companies
View All Buyers Guide Companies »
Contract Service Directory Categories
View All Categories »
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Lonza Further Invests in Drug Product Manufacturing Capabilities
New filling line to process various modalities, including monoclonal antibodies, bioconjugates, viral vectors, and other gene therapy products.09.22.21
-
Breaking News | Clinical Trials
pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray
According to the study, the novel prophylactic nasal spray prevented infection from SARS-CoV-2, the virus that causes COVID-19.09.22.21
-
Breaking News | Drug Development | Drug Discovery | Industry News
Rentschler Biopharma to Support Albert Einstein Discovery Center
Donates 50,000 Euros to support the creation of the discovery and activity center in Ulm.09.22.21
-
Breaking News | Industry News | Laboratory Testing
Metrion Biosciences Expands into New Cambridge HQ
New 12,000 sq. ft. Cambridge, UK premises more than doubles lab space.09.22.21
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials
Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany
Covers the combination of DHODH inhibitors and nucleoside analogues to treat viral infections, including Covid-19.09.22.21
-
Breaking News | Drug Development | Industry News
Veklury Reduced Risk of Hospitalization in High-Risk COVID-19 Patients
Veklury demonstrated a statistically significant 87% reduction in risk for the composite primary endpoint of COVID-19 related hospitalization.09.22.21
-
Breaking News | Clinical Trials
First Patient is Dosed with Triumvira's Investigational TAC-T Cell Adoptive Immunotherapy
TAC01-HER2 was developed for the treatment of HER2-overexpressing cancers.09.21.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
J&J Data Confirms Strong and Long-Lasting Protection of COVID-19 Vax
Phase 3 ENSEMBLE trial shows booster shot at two months provided 94 percent protection against COVID-19 in the U.S.09.21.21
-
Breaking News | Formulation Development
Recro Pharma Signs Renewable Energy Agreement with Georgia Power
Will purchase 1.2 million renewable energy credits through Georgia Power’s Simple Solar Program.09.21.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate
Will initiate the GMP manufacturing of the clinical batches of FluGen’s M2SR influenza vaccine candidate for upcoming clinical trials.09.21.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
CuriRx Launches CuriLytics Platform for Biotherapeutic Development
To provide CMC analytical services to support complex biotherapeutic development using high resolution mass spectrometry.09.21.21
-
-
Strategies to Successfully Transfer & Scale Rx & OTC Drugs
Bora’s Technology Transfer Whitepaper will help you discover key strategies to successfully transfer and scale Rx & OTC drugs.
-
Biologics, Proteins, Vaccines | Reader Showcase
Thermo Fisher Launches Gibco AAV Production System
Aims to address the need to make adeno-associated virus (AAV) production more efficient and scalable.09.20.21
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News
Oxford Bio Advances Boehringer Oncology Candidate
Receives another milestone payment from Boehringer Ingelheim for progressing a second oncology drug candidate (BI 765049) into the clinic.09.20.21
-
Breaking News | Promotions & Moves
Rentschler Biopharma Appoints Dr. Christian Schetter as Chief Scientific Officer
Schetter has a proven track record across the entire biopharmaceutical value chain.09.20.21
-
-
Breaking News | cGMP Manufacture | Drug Development | Industry News
Everest Medicines, Sinovent, SinoMab Enter Global BTK Inhibitor Mfg. Pact
To develop, produce and commercialize XNW1011, a covalent reversible BTK inhibitor, globally for the treatment of renal diseases.09.17.21
-
Breaking News | Industry News
Lilly’s Antibody Treatment Gets EUA for Post-Exposure COVID Prevention
Phase 3 study shows bamlanivimab 4200 mg reduced the risk of contracting symptomatic COVID-19 by up to 80 percent in nursing home residents.09.17.21
-
Breaking News | Collaborations & Alliances | Industry News
Asychem Partners with LaNova Medicines
Will provide one-stop services such as small molecule drugs, ADC project CMCs, R&D, production and IND China-US declaration.09.16.21
-
Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
Tevogen Completes Tech Transfer to CDMO BioCentriq
Reaches commercial manufacturing readiness milestone for its investigational COVID-19 therapy TVGN-489.09.16.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News | Parenterals
BioVaxys Reports Progress on Covid-19 Vax Candidate
Bioproduction partner Wuxi Biologics completes synthesis of recombinant SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH programs.09.16.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Vaccine Developer Intravacc Adopts Hybrid Business Model
Aims to spur further innovation and sustainable growth over the next five years.09.16.21
-
Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Clean Cells Expands Bioproduction Capabilities
Invests $15.3 million in new biopharmaceutical production site.09.16.21
-
Breaking News | Facilities | Industry News | Inspections
Symbiosis Completes Successful MHRA Audit
Will expand facility at its Stirling, UK site with new storage and warehousing capability.09.16.21
-
Breaking News | Cold Chain Management | Facilities | Industry News | Packaging & Tracking
Tower Cold Chain to Open New Global Headquarters in the UK
The 26,000 sq. ft building will greatly expand Tower’s container conditioning and storage capacities.09.16.21
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Solid Dosage/Creams/Ointments
Catalent Signs Commercial Supply Agreement with Phathom Pharmaceuticals
Will make lead compound vonoprazan from Winchester, KY facility if approved by FDA.09.16.21
-
Breaking News | Clinical Trials
Syneos Health Acquires Clinical Trial Recruitment and Retention Company StudyKIK
Accelerates product development by better connecting patients, sites and communities.09.15.21
-
Breaking News | Drug Development | Industry News
Diadem Biotherapeutics Awarded the First Amgen Golden Ticket
Will receive one year of lab space at BioLabs LA at The Lundquist Institute and additional facility benefits and connections to Amgen's scientific leaders.09.15.21
-
Breaking News | Industry News
U.S. Govt. to Purchase Additional Doses of REGEN-COV Antibody Cocktail
Will supply an additional 1.4 million 1,200 mg doses of REGEN-COV to the U.S. government by January 31, 2022.09.15.21
-
Breaking News | Information Technology
LabVantage Solutions Launches LabVantage Enterprise SaaS
Incorporates the advantages of LabVantage’s standard SaaS option, along with unprecedented software configurability and interfacing capabilities.09.15.21
-
Breaking News | Clinical Trials | Collaborations & Alliances
Hookipa Enters Clinical Collaboration & Supply Agreement with Merck & Co.
Will evaluate HB-200 in combination with Keytruda (pembrolizumab) in patients with advanced head and neck cancers.09.15.21
-
Breaking News | Drug Development | Drug Discovery | Industry News | Information Technology
Novo Nordisk Launches Foundation Center for Genomic Mechanisms of Disease
Initiative, together with the Broad Institute of MIT and Harvard, aims to accelerate efforts to mine genetic data for insights into disease mechanisms.09.15.21
-
Breaking News | Industry News
U.S. Govt. Purchases Additional Doses of Lilly's Antibody Therapies for COVID
Will supply 388,000 doses of etesevimab to complement doses of bamlanivimab previously purchased, with approximately 200,000 doses expected to ship 3Q21.09.15.21
-
-
-
-
-
-
-
Biologics, Proteins, Vaccines
CEO Spotlight: Gaston Salinas, Botanical Solution Inc.
QS-21 has become the ‘Gold Standard’ for human vaccine adjuvants and BSI is positioned to become a reliable supplier to the pharmaceutical market.Tim Wright, Editor, Contract Pharma 09.14.21
-
Pii Expands Sterile Fill-Finish Capacity and Capabilities
Increases its ability to perform Large Volume Sterile Fill-Finish production needed for manufacturing most vaccinations.09.14.21
-
Breaking News | Industry News | Promotions & Moves
Aurion Biotech Makes Strategic Investments in Manufacturing
Appoints Tim Largen as VP of manufacturing to drive cell therapy production strategy and direct collaborations with leading CDMOs.09.14.21
-
Breaking News | Collaborations & Alliances | Industry News
Lakes BioScience Signs Agreement with Cytvia
Initiates the implementation of innovative workflows at Lakes BioScience’s factory in Cumbria.09.14.21
-
Drug Development | Laboratory Testing
Eliminating Endotoxins – Reagent Quality Testing for Cell and Gene Therapies
The importance of reagent quality control, especially endotoxin testing, during CGT development and the selection of reagents and suppliers to ensure safety.Garrett Perry, Technical Services Specialists at Teknova 09.14.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Emergent BioSolutions, Providence Therapeutics Enter Vaccine Manufacturing Partnership
Ink multi-year development and manufacturing agreement for mRNA COVID-19 vaccine candidate, PTX-COVID19-B.09.14.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
AGC Biologics Expands pDNA and mRNA Manufacturing Capacity
Expansion at Heidelberg site allows the CDMO to meet increasing demands of the cell and gene therapy market.09.14.21
-
Breaking News | Industry News
Samsung Biologics to Participate in Frontier 1.5D Initiative
Will develop a climate risk management model as part of 2050 Carbon Neutral Strategy in response to the challenges associated with climate change.09.14.21
-
Breaking News | CRO News | Drug Discovery | Industry News | Preclinical Outsourcing
Frontage Expands Early Drug Discovery Services
Acquires majority stake in Wuhan Heyan Biomedical Technology.09.14.21
-
Breaking News | Promotions & Moves
Tekni-Plex Names Chris Qualters as CEO of Healthcare Division
To oversee all businesses related to healthcare, encompassing product solutions for medical devices, diagnostics, drug delivery and sterilizable materials.09.13.21
